Lacnotuzumab (Anti-CSF1 / M-CSF) | Read Reviews & Product Use Citations

Lacnotuzumab (Anti-CSF1 / M-CSF) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1, that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis. MW: 150 KD.

Click to purchase the isotype control of Lacnotuzumab (Anti-CSF1 / M-CSF)

Purity & Quality Control

Batch: A253401 Purity: 99% Protein concentration: 6.25mg/ml Endotoxin Level: ＜1EU/mg

99

Biological Activity

Description	Lacnotuzumab (Anti-CSF1 / M-CSF) is a neutralizing humanized IgG1/κ monoclonal antibody targeting CSF-1, that prevents CSF-1 from activating the CSF-1R. Lacnotuzumab can be used for the research of pigmented villonodular synovitis. MW: 150 KD.

Product Details

CAS No.	1831128-32-5
Molecular Weight	150 kDa
Isotype	Human IgG1
Source	CHO
Purification	AKTA
Sterility	0.2 μM filtered
Formulation	100mMPro-Ac,20mMArg-Ac，pH5.0
Storage (From the date of receipt)	Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field